EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue

Samrin Kagdi, Sulayman A Lyons, Jacqueline L Beaudry iD

Journal of Endocrinology · 03.04.2024 · 261 (3)

DOI: 10.1530/joe-23-0361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, erschienen am 03.04.2024. Verfasst von Samrin Kagdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Gastric Inhibitory Polypeptide, Adipose Tissue, Receptors, Gastrointestinal Hormone. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose tissue was once known as a reservoir for energy storage but is now considered a crucial organ for hormone and energy flux with important effects on health and disease. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone secreted from the small intestinal K cells, responsible for augmenting insulin release, and has gained attention for its independent and amicable effects with glucagon-like peptide 1 (GLP-1), another incretin hormone secreted from the small intestinal L cells. The GIP receptor (GIPR) is found in whole adipose tissue, whereas the GLP-1 receptor (GLP-1R) is not, and some studies suggest that GIPR action lowers body weight and plays a role in lipolysis, glucose/lipid uptake/disposal, adipose tissue blood flow, lipid oxidation, and free-fatty acid (FFA) re-esterification, which may or may not be influenced by other hormones such as insulin. This review summarizes the research on the effects of GIP in adipose tissue (distinct depots of white and brown) using cellular, rodent, and human models. In doing so, we explore the mechanisms of GIPR-based medications for treating metabolic disorders, such as type 2 diabetes and obesity, and how GIPR agonism and antagonism contribute to improvements in metabolic health outcomes, potentially through actions in adipose tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric Inhibitory PolypeptideAdipose TissueReceptors, Gastrointestinal HormoneHumansAnimalsGlucoseLipolysisObesity

Stichwörter der Autor:innen

brown adipose tissueenergy expenditureenergy metabolismglucagon-like peptide 1glucose controlglucose-dependent insulinotropic polypeptideinsulin sensitivitylipid metabolism obesityresting energy expendituretype 2 diabetes mellituswhite adipose tissue

Substanzen

Gastric Inhibitory PolypeptideReceptors, Gastrointestinal Hormonegastric inhibitory polypeptide receptorGlucose

Autor:innen und Institutionen

  • Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Jacqueline L Beaudry

Zitieren

APA

Kagdi, S., Lyons, S. A., & Beaudry, J. L. (2024). The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. Journal of Endocrinology, 261(3). https://doi.org/10.1530/joe-23-0361

Vancouver

Kagdi S, Lyons SA, Beaudry JL. The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. Journal of Endocrinology. 2024;261(3). doi:10.1530/joe-23-0361

BibTeX
@article{Kagdi2024,
  author = {Kagdi, Samrin and Lyons, Sulayman A and Beaudry, Jacqueline L},
  title = {The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue},
  journal = {Journal of Endocrinology},
  year = {2024},
  volume = {261},
  number = {3},
  doi = {10.1530/joe-23-0361}
}
Kostenlos starten →